Last: | $0.48 |
---|---|
Change Percent: | 8.35% |
Open: | $0.468 |
Close: | $0.443 |
High: | $0.4975 |
Low: | $0.4465 |
Volume: | 223,354 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.48 | $0.468 | $0.443 | $0.4975 | $0.4465 | 223,354 | 03-28-2024 |
$0.443 | $0.45 | $0.443 | $0.456 | $0.43 | 152,625 | 03-27-2024 |
$0.439 | $0.44 | $0.439 | $0.45 | $0.4202 | 231,694 | 03-26-2024 |
$0.44 | $0.47 | $0.44 | $0.489 | $0.43 | 931,165 | 03-25-2024 |
$0.4437 | $0.381 | $0.4437 | $0.445 | $0.381 | 197,288 | 03-22-2024 |
$0.381 | $0.429 | $0.381 | $0.43 | $0.375 | 108,634 | 03-21-2024 |
$0.4001 | $0.4 | $0.4001 | $0.43 | $0.368 | 219,968 | 03-20-2024 |
$0.405 | $0.409 | $0.405 | $0.4402 | $0.38 | 749,813 | 03-19-2024 |
$0.375 | $0.33 | $0.375 | $0.4 | $0.33 | 360,468 | 03-18-2024 |
$0.33 | $0.33 | $0.33 | $0.349 | $0.33 | 61,935 | 03-15-2024 |
$0.3335 | $0.38 | $0.3335 | $0.38 | $0.3201 | 274,395 | 03-14-2024 |
$0.36 | $0.364 | $0.36 | $0.37 | $0.3521 | 133,796 | 03-13-2024 |
$0.355 | $0.3583 | $0.355 | $0.3749 | $0.355 | 145,381 | 03-12-2024 |
$0.36 | $0.38 | $0.36 | $0.385 | $0.36 | 176,194 | 03-11-2024 |
$0.378 | $0.3825 | $0.378 | $0.4 | $0.372 | 89,611 | 03-08-2024 |
$0.384 | $0.39 | $0.384 | $0.3987 | $0.38 | 45,471 | 03-07-2024 |
$0.3895 | $0.3949 | $0.3895 | $0.3949 | $0.3615 | 211,961 | 03-06-2024 |
$0.395 | $0.404 | $0.395 | $0.41 | $0.39 | 84,930 | 03-05-2024 |
$0.395 | $0.395 | $0.395 | $0.406 | $0.388 | 129,078 | 03-04-2024 |
$0.4006 | $0.391 | $0.4006 | $0.4101 | $0.391 | 70,611 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
AIM ImmunoTech Inc. Company Name:
AIM Stock Symbol:
NYSE Market:
OCALA, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that Thomas K. Equels, ...
OCALA, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM ImmunoTech, will present at the MedInvest Biotech & Phar...
OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to discuss the Company’s Q4/FY2023 operational and financial...